Carregant...
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120/MF59 in Adults
BACKGROUND: A safe, effective vaccine is essential to end HIV. A canarypox/protein HIV vaccine regimen showed modest efficacy at reducing infection in Thailand. An analogous regimen using HIV-1 subtype C virus demonstrated potent humoral and cellular responses in a Phase 1/2a trial and triggered a P...
Guardat en:
| Publicat a: | N Engl J Med |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Massachusetts Medical Society
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7888373/ https://ncbi.nlm.nih.gov/pubmed/33761206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2031499 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|